Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q4 2025 (December 31)8holders +2
4new positions
1sold out
$1.62avg. 13F price*
At the end of Q4 2025, 8 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, up 2 from Q3 2025. 4 opened new positions and 1 sold out. The largest holders were Focus Partners Wealth ($8.3M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($5.0M) and State of Wisconsin Investment Board ($4.8M).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $8.4M |
| Exits | 1 | $14.8M |
All 13F filers, Q3 2025 → Q4 2025: 5,944,124 shares bought and 277,195 shares sold, net +5,666,929 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Focus Partners Wealth | 0.01% | New | 5,283,000 | $8.3M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Add +25.4% | 3,135,000 | $5.0M |
| State of Wisconsin Investment Board | 0.01% | No change | 3,000,000 | $4.8M |
| Nomura Holdings Inc. | 0.00% | Reduce -90.4% | 5,025 | $398K |
| Sei Investments Co. | 0.00% | Reduce -59.9% | 105,000 | $167K |
| NewEdge Advisors, LLC | 0.00% | New | 13,000 | $21K |
| Boussard & Gavaudan Investment Management LLP | 0.00% | New | 12,750 | $20K |
| Oddo BHF Asset Management Sas | 0.00% | New | 374 | $595 |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.